Our vision is to enable the development of safe, yet effective therapies for disease treatment. Our HDAC6 drug discovery project was spearheaded by serial entrepreneur Patrick Gunning, who has spun out two previous ventures from his academic lab. Our team of innovative scientists apply a holistic approach of integrating biology, chemistry and technology to tailor epigenetic drug candidates for hematopoietic cancers and CNS disorders.